|
|
||||||||||||||
|
|
|||||||||||||||
COMMENTARY |
1 Pinney Associates Inc, Bethesda, Maryland, USA and Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
2 University of California San Francisco, San Francisco, California, USA
3 Harvard University School of Public Health, Boston, Massachusetts, USA
4 Henry Ford Health System, Detroit, Michigan, USA
5 International Agency for Research on Cancer, Lyon, France
6 Campaign for Tobacco-Free Kids, Washington, DC, USA
7 Pinney Associates, Inc, Bethesda, Maryland, USA
Correspondence to:
Jack E Henningfield PhD
Pinney Associates, Inc, 4800 Montgomery Lane, Suite 1000, Bethesda, MD 20814, USA; jhenning{at}pinneyassociates.com
ABSTRACT
Tobacco product regulation has the potential to help reduce tobacco attributable disease by reducing the toxicity of these products and by reducing the prevalence of tobacco use and addiction
Abbreviations: FCTC, Framework Convention on Tobacco Control; FDA, Food and Drug Administration; FTC, Federal Trade Commission; ISO, International Organization for Standardization
Keywords: addiction; harm reduction; ingredient; regulation
This article has been cited by other articles:
![]() |
C. E. Koop Health and Health Care for the 21st Century: For All the People Oncologist, April 1, 2007; 12(4): 366 - 369. [Full Text] [PDF] |
||||
![]() |
C. E. Koop Health and Health Care for the 21st Century: For All the People Am J Public Health, December 1, 2006; 96(12): 2090 - 2092. [Full Text] [PDF] |
||||
![]() |
J. E Henningfield, C. A Rose, and M. Zeller Tobacco industry litigation position on addiction: continued dependence on past views Tob. Control, December 1, 2006; 15(suppl_4): iv27 - iv36. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Pletcher, B. J. Hulley, T. Houston, C. I. Kiefe, N. Benowitz, and S. Sidney Menthol Cigarettes, Smoking Cessation, Atherosclerosis, and Pulmonary Function: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arch Intern Med, September 25, 2006; 166(17): 1915 - 1922. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Ferris Wayne, G N Connolly, and J E Henningfield Brand differences of free-base nicotine delivery in cigarette smoke: the view of the tobacco industry documents Tob. Control, June 1, 2006; 15(3): 189 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lewis and O. Wackowski Dealing With an Innovative Industry: A Look at Flavored Cigarettes Promoted by Mainstream Brands Am J Public Health, February 1, 2006; 96(2): 244 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Gray, J E Henningfield, N L Benowitz, G N Connolly, C Dresler, K Fagerstrom, M J Jarvis, and P Boyle Toward a comprehensive long term nicotine policy Tob. Control, June 1, 2005; 14(3): 161 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Mazzone and A. C. Arroliga How Many Ways Can We Say That Cigarette Smoking Is Bad for You? Chest, December 1, 2004; 126(6): 1717 - 1718. [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |